Latest filing published 06 Jul 2021 for Elicera Therapeutics AB (publ), €9,747.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Karin helene Hoogendoorn: trading record in brief
Karin helene Hoogendoorn appears in our data through filings on Elicera Therapeutics AB (publ) shares, published by Finansinspektionen. Over a trading history stretching from 6 June 2021 to 5 July 2021, the count stands at 3 filings.
On the market, this insider has only ever bought: 1 purchase, €9,747 in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 2 share grants.
The record was last updated on 6 July 2021 with an open-market purchase (€9,747) in Elicera Therapeutics AB (publ). Typically, a trade is published a median of 10 days after it takes place. The regulation allows three business days to notify a trade (MAR article 19). These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Companies and markets linked to Karin helene Hoogendoorn
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 23,000 shares@ SEK 4.3049.5% of flowAktieISIN SE0015382080FI:csv-57b74fd02105eefc1d91Canonical exit: 3 Oct 2021 (T+90)
- 12,500 shares0WarrantISIN SE0015988233FI:csv-144f614d0cfa7577285a
- 12,500 shares@ SEK 8.0050.5% of flowAktieISIN SE0015382080FI:csv-b62d4280daa3cb28afce
3 of 3 declarations